Series B - Ensoma
Investment Firm
Overview
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Announced Date
May 16, 2023
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Delos Capital |
Round Details and Background
Ensoma raised $50000000 on 2023-05-16 in Series B
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 11, 2021 |  Series A - Ensoma | 8 | - | 70.0M |
| Jan 05, 2023 | Series B - Ensoma | 14 | - | 85.0M |
| May 16, 2023 | Series B - Ensoma | 4 | - | 50.0M |
Recent Activity
There is no recent news or activity for this profile.